Health and Fitness Health and Fitness
Tue, February 5, 2013
Mon, February 4, 2013
Sun, February 3, 2013
Sat, February 2, 2013
Fri, February 1, 2013
Thu, January 31, 2013
Wed, January 30, 2013
Tue, January 29, 2013
[ Tue, Jan 29th 2013 ] - Market Wire
AtheroNova Launches New Website
Mon, January 28, 2013
Sun, January 27, 2013
Sat, January 26, 2013
Fri, January 25, 2013
Thu, January 24, 2013
Wed, January 23, 2013
Tue, January 22, 2013
Mon, January 21, 2013
Fri, January 18, 2013
Thu, January 17, 2013
Wed, January 16, 2013
Tue, January 15, 2013
Mon, January 14, 2013
Fri, January 11, 2013
Thu, January 10, 2013
Wed, January 9, 2013
Tue, January 8, 2013
[ Tue, Jan 08th 2013 ] - Market Wire
Cambridge Heart Provides Update

Ryan amp;; Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.


//health-fitness.news-articles.net/content/2013/ .. es-investigation-of-map-pharmaceuticals-inc.html
Published in Health and Fitness on Thursday, January 24th 2013 at 8:45 GMT by Market Wire   Print publication without navigation


Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc. -- WAYNE, Pa., Jan. 24, 2013 /PRNewswire/ --

WAYNE, Pa., Jan. 24, 2013 /PRNewswire/ -- [ Ryan & Maniskas, LLP ] ([ www.rmclasslaw.com/cases/mapp ]) is investigating potential claims against the board of directors of MAP Pharmaceuticals, Inc. ("MAP" or the "Company") (NASDAQ: [ MAPP ]) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Allergan, Inc. in a transaction valued at approximately $958 million.

(Logo: [ http://photos.prnewswire.com/prnh/20121112/MM11729LOGO ] )

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by the Company's board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of MAP.  For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire ) toll-free at (877) 316-3218 or by email at [ rmaniskas@rmclasslaw.com ] or visit: [ www.rmclasslaw.com/cases/mapp ].         

Under the terms of the proposal, public shareholders of MAP will receive $25.00 per share in cash for each share of MAP they own.

If you own shares of MAP and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: [ www.rmclasslaw.com/cases/mapp ].  You may also email Mr. Maniskas at [ rmaniskas@rmclasslaw.com ].  For more information about class action cases in general, please visit our website: [ www.rmclasslaw.com ].

Ryan & Maniskas, LLP is a national shareholder litigation firm.  Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

CONTACT:

Ryan & Maniskas, LLP


Richard A. Maniskas, Esquire


995 Old Eagle School Rd., Suite 311


Wayne, PA 19087


877-316-3218


[ www.rmclasslaw.com/cases/mapp ]    


[ rmaniskas@rmclasslaw.com ]

SOURCE Ryan & Maniskas, LLP



RELATED LINKS
[ http://www.rmclasslaw.com ]

Publication Contributing Sources